Grants and Contracts Details
Description
Spinal cord injury (SCI) produces a chronic inflammatory state primarily mediated by resident microglia
and infiltrating monocytes (here, collectively referred to as macrophages). These chronically activated SCI
macrophages adopt a pro-inflammatory, pathological state that continues to cause additional damage after the
initial injury and inhibits recovery. Myelin debris generated after SCI can directly stimulate macrophages to
adopt these maladaptive functions; however, the mechanisms by which this stimulation occur are poorly
understood. Myelin contains an inflammatory lipid molecule, arachidonic acid, stored in an inactive form within
myelin’s extensive membranes. After injury, macrophages clear and accumulate myelin debris long after injury.
Here, we propose that the inflammatory environment within the SCI lesion induces the expression of the
enzyme cytosolic phospholipase A2 (cPLA2) within macrophages. cPLA2 releases arachidonic acid from
cellular membranes. Free, active arachidonic acid invokes direct pro-inflammatory functions or, through
synthesis, forms various eicosanoids with pro-inflammatory properties. This is the basis for the central
hypothesis that increased cPLA2 activity in SCI macrophages releases arachidonic acid from myelin
debris thereby driving chronic SCI inflammation and tissue damage. .
Using in-vitro and in-vivo approaches, Aim 1 of this proposal will identify cPLA2 as the regulator of
myelin-mediated inflammation in macrophages. We will thereby demonstrate the importance of myelin-derived
arachidonic acid in these critical inflammatory responses. Aim 2 will utilize cPLA2-/- bone marrow chimeric mice
to interrogate the importance and influence of macrophage cPLA2 in the pathogenesis of SCI. Chronic proinflammatory
macrophage activation is a key mediator of secondary damage and impaired recovery after SCI,
yet the mechanisms behind this process are poorly understood. Here I propose a novel mechanism by which
myelin debris and subsequent processing by macrophage cPLA2 continuously produces free arachidonic acid
thereby driving the chronic inflammation observed after SCI.
Status | Finished |
---|---|
Effective start/end date | 7/1/18 → 6/30/19 |
Funding
- National Institute of Neurological Disorders & Stroke: $32,470.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.